Overall rank by patents
#39,758
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
DEEP Brain Stimulation Technologies PTY. Ltd.
USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
6
Total patents granted
4
CPC technology areas
23.3
Avg claims per patent
-
5-year filing velocity
The verdict
DEEP holds 6 US patents across 4 technology areas, rank #39,758 of 50,000 tracked assignees.
- #39,758
- of 50,000 US assignees by volume
- Top 18%
- by Innovation Score (47.8/100)
- 23.3
- avg claims per patent
Portfolio overview
DEEP Brain Stimulation Technologies PTY. Ltd. has been granted 6 US utility patents between 2021 and 2024, placing DEEP Brain Stimulation Technologies PTY. Ltd. at rank #39,758 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.3 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, DEEP Brain Stimulation Technologies PTY. Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, DEEP sits between DCI Marketing, Inc. (6 patents, rank #39,754) and Dental Innovations, Llc (6 patents, rank #39,762) - the closest US assignees by grant volume. The composite Innovation Score of 47.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. DEEP Brain Stimulation Technologies PTY. Ltd.'s 23.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark DEEP Brain Stimulation Technologies PTY. Ltd. against peers pursuing similar technology classes.
Who files at DEEP's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- DCI Marketing
DCI Marketing, Inc.
6 patents
- DE Montfort Unive…
DE MONTFORT UNIVERSITY
6 patents
- Decathlon
DECATHLON S.A.
6 patents
- Decked
DECKED, LLC
6 patents
- Degrii
DEGRII CO., LTD.
6 patents
- Delcotto IP
DELCOTTO IP, LLC
6 patents
- Delta PLUS Group
DELTA PLUS GROUP
6 patents
- Dental Innovations
DENTAL INNOVATIONS, LLC
6 patents
- DEEP Brain Stimul… ◀
DEEP BRAIN STIMULATION TECHNOLOGIES PTY. LTD.
6 patents
What this shows DEEP holds 6 patents at rank #39,758, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near DEEP
By rank, the assignees closest to #39,758 in granted patent volume.
- DCI Marketing, Inc. #39,754 · 6 patents
- DE Montfort University #39,755 · 6 patents
- Decathlon S.a. #39,756 · 6 patents
- Decked, Llc #39,757 · 6 patents
- Degrii Co., Ltd. #39,759 · 6 patents
- Delcotto IP, Llc #39,760 · 6 patents
- Delta PLUS Group #39,761 · 6 patents
- Dental Innovations, Llc #39,762 · 6 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in DEEP's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- ZOLL Medical Corporation 556 in class
- Koniniklijke Philips N.v. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
DEEP's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 16.7% |
| 2022 | 3 | 50.0% |
| 2024 | 2 | 33.3% |
Which technologies does DEEP Brain Stimulation Technologies PTY. Ltd. patent most?
Top 4 of 4 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Frequently Asked Questions
How many patents does DEEP Brain Stimulation Technologies PTY. Ltd. hold?
DEEP Brain Stimulation Technologies PTY. Ltd. holds 6 US granted patents filed between 2021 and 2024, spanning 4 technology areas.
What is DEEP Brain Stimulation Technologies PTY. Ltd.'s Innovation Score?
DEEP Brain Stimulation Technologies PTY. Ltd. has an Innovation Score of 47.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does DEEP Brain Stimulation Technologies PTY. Ltd. focus on?
DEEP Brain Stimulation Technologies PTY. Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 6 patents. The company has filed patents in 4 CPC subclasses total.
Is DEEP Brain Stimulation Technologies PTY. Ltd.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for DEEP Brain Stimulation Technologies PTY. Ltd..
What does claim depth mean for DEEP Brain Stimulation Technologies PTY. Ltd.'s patents?
DEEP Brain Stimulation Technologies PTY. Ltd.'s patents average 23.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the DEEP Brain Stimulation Technologies PTY. Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
DEEP's 6 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - DEEP ranks #39,758 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.